Unlock stock picks and a broker-level newsfeed that powers Wall Street.
3.0100
+0.1500
+(5.24%)
At close: 4:00:01 PM EDT
3.0000
-0.01
(-0.33%)
After hours: 5:30:22 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 3 |
| Avg. Estimate | -0.13 | -0.13 | -0.51 | -0.33 |
| Low Estimate | -0.14 | -0.15 | -0.62 | -0.43 |
| High Estimate | -0.12 | -0.11 | -0.46 | -0.13 |
| Year Ago EPS | -0.11 | -0.12 | -0.48 | -0.51 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 6 |
| Avg. Estimate | -- | -- | -- | 40.5M |
| Low Estimate | -- | -- | -- | 15.79M |
| High Estimate | -- | -- | -- | 71.12M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.1 | -0.11 | -0.11 | -0.11 |
| EPS Actual | -0.11 | -0.12 | -0.11 | -0.13 |
| Difference | -0.01 | -0.01 | 0 | -0.02 |
| Surprise % | -13.79% | -12.50% | 0.00% | -14.04% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.13 | -0.13 | -0.51 | -0.33 |
| 7 Days Ago | -0.11 | -0.11 | -0.46 | -0.2 |
| 30 Days Ago | -0.11 | -0.11 | -0.46 | -0.2 |
| 60 Days Ago | -0.11 | -0.11 | -0.46 | -0.2 |
| 90 Days Ago | -0.11 | -0.11 | -0.46 | -0.2 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 2 | 2 | 4 | 2 |
| Down Last 30 Days | 2 | 1 | 3 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SVRA | -16.36% | -5.00% | -7.08% | 36.45% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
| Initiated | Wells Fargo: Overweight | 12/20/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 12/19/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/13/2024 |
| Downgrade | Evercore ISI Group: Outperform to In-Line | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/8/2024 |
Related Tickers
THAR Tharimmune, Inc.
1.2900
-1.53%
CMPX Compass Therapeutics, Inc.
1.6900
-24.55%
KROS Keros Therapeutics, Inc.
10.04
+5.13%
PHGE BiomX Inc.
0.6290
+27.59%
AARD Aardvark Therapeutics, Inc. Common Stock
9.35
+12.79%
TECX Tectonic Therapeutic, Inc.
17.89
+6.24%
EWTX Edgewise Therapeutics, Inc.
15.52
-22.90%
TARS Tarsus Pharmaceuticals, Inc.
51.49
+5.25%
VERA Vera Therapeutics, Inc.
23.59
+7.13%
SPRO Spero Therapeutics, Inc.
0.7060
+1.73%